Armata Pharmaceuticals (ARMP) Preferred Shares (2013 - 2014)
Armata Pharmaceuticals' (ARMP) quarterly Preferred Shares came in at $87000.0 in Q3 2014, little changed quarter-over-quarter from $87000.0 in Q2 2014.
Armata Pharmaceuticals (ARMP) Preferred Shares (2013 - 2014) Analysis & Trends
Armata Pharmaceuticals has disclosed Preferred Shares across 2 years of filings, most recently posting $87000.0 for Q3 2014.
- Preferred Shares for Q3 2014 came in at $87000.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2014 was $87000.0 (changed N/A YoY), and the FY2013 annual result was $89000.0, changed N/A from the prior year.
- Preferred Shares came in at $87000.0 for Q3 2014 at Armata Pharmaceuticals, roughly flat from $87000.0 in the prior quarter.
- In the past five years, Preferred Shares ranged from a high of $89000.0 in Q4 2013 to a low of $87000.0 in Q2 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Armata Pharmaceuticals | 275.44 Mn | 270.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2014 | 87,000.00 |
| Jun 30, 2014 | 87,000.00 |
| Mar 31, 2014 | 89,000.00 |
| Dec 31, 2013 | 89,000.00 |